These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 1546744)

  • 1. Induction in mice of human light-chain-associated amyloidosis.
    Solomon A; Weiss DT; Pepys MB
    Am J Pathol; 1992 Mar; 140(3):629-37. PubMed ID: 1546744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
    Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
    Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of human smooth muscle cells to amyloid angiopathy in AL (light-chain) amyloidosis.
    Vora M; Kevil CG; Herrera GA
    Ultrastruct Pathol; 2017; 41(5):358-368. PubMed ID: 28796568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
    Shimamoto Y; Takahashi N; Katoh N; Matsui Y; Mochizuki Y; Ito M; Yazaki M; Kametani F; Kasuno K; Sekijima Y; Naiki H; Iwano M
    BMC Nephrol; 2023 Jun; 24(1):187. PubMed ID: 37365566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin heavy-chain-associated amyloidosis.
    Eulitz M; Weiss DT; Solomon A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
    Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
    Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).
    Odani S; Komori Y; Gejyo F
    Amyloid; 1999 Jun; 6(2):77-88. PubMed ID: 10439113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary amyloidosis associated with a novel heavy-chain fragment (AH amyloidosis).
    Solomon A; Weiss DT; Murphy C
    Am J Hematol; 1994 Feb; 45(2):171-6. PubMed ID: 8141123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of monoclonal antibody against amyloid fibril protein and its immunohistochemical application.
    Kurashima C; Hirokawa K
    Appl Pathol; 1985; 3(1-2):39-54. PubMed ID: 3915946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease.
    Kaplan B; Livneh A; Gallo G
    Br J Haematol; 2007 Mar; 136(5):723-8. PubMed ID: 17223908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iatrogenic, insulin-dependent, local amyloidosis.
    Störkel S; Schneider HM; Müntefering H; Kashiwagi S
    Lab Invest; 1983 Jan; 48(1):108-11. PubMed ID: 6337294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bence-Jones protein-type myeloma with amyloid myopathy presenting as amyloidomas and extensive amyloid deposits in the muscularis propria: a rapidly fatal autopsy case.
    Ikezawa Y; Oka K; Nagayama R; Okubo Y; Yonekawa N; Hirai F; Ebihara I; Mori N
    Int J Surg Pathol; 2012 Feb; 20(1):83-8. PubMed ID: 21632635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin D myeloma and amyloidosis: immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins.
    White GC; Jacobson RJ; Binder RA; Linke RP; Glenner GG
    Blood; 1975 Nov; 46(5):713-22. PubMed ID: 809071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.